BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 34402889)

  • 1. Estimated Cost-effectiveness of Endoscopic Screening for Upper Gastrointestinal Tract Cancer in High-Risk Areas in China.
    Xia R; Zeng H; Liu W; Xie L; Shen M; Li P; Li H; Wei W; Chen W; Zhuang G
    JAMA Netw Open; 2021 Aug; 4(8):e2121403. PubMed ID: 34402889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution microendoscopy for esophageal cancer screening in China: A cost-effectiveness analysis.
    Hur C; Choi SE; Kong CY; Wang GQ; Xu H; Polydorides AD; Xue LY; Perzan KE; Tramontano AC; Richards-Kortum RR; Anandasabapathy S
    World J Gastroenterol; 2015 May; 21(18):5513-23. PubMed ID: 25987774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of risk-stratified endoscopic screening for esophageal cancer in high-risk areas of China: a modeling study.
    Xia R; Li H; Shi J; Liu W; Cao M; Sun D; He S; Yu Y; Li N; Lei L; Zhuang G; Chen W
    Gastrointest Endosc; 2022 Feb; 95(2):225-235.e20. PubMed ID: 34418461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis.
    Gupta N; Bansal A; Wani SB; Gaddam S; Rastogi A; Sharma P
    Gastrointest Endosc; 2011 Sep; 74(3):610-624.e2. PubMed ID: 21741639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age at Initiation and Frequency of Screening to Prevent Esophageal Squamous Cell Carcinoma in High-risk Regions: an Economic Evaluation.
    Wu B; Wang Z; Zhang Q
    Cancer Prev Res (Phila); 2020 Jun; 13(6):543-550. PubMed ID: 32152149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication.
    Kowada A
    Dig Dis Sci; 2021 Dec; 66(12):4220-4226. PubMed ID: 33417196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Benefit and Cost Effectiveness of Risk-Stratified Gastric Cancer Screening Strategies in China: A Modeling Study.
    Qin S; Wang X; Li S; Tan C; Zeng X; Luo X; Yi L; Peng L; Wu M; Peng Y; Wang L; Wan X
    Pharmacoeconomics; 2022 Jul; 40(7):725-737. PubMed ID: 35701687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation.
    Su S; Wong WC; Zou Z; Cheng DD; Ong JJ; Chan P; Ji F; Yuen MF; Zhuang G; Seto WK; Zhang L
    Lancet Glob Health; 2022 Feb; 10(2):e278-e287. PubMed ID: 35063115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis.
    Zou Z; Fairley CK; Ong JJ; Hocking J; Canfell K; Ma X; Chow EPF; Xu X; Zhang L; Zhuang G
    Lancet Glob Health; 2020 Oct; 8(10):e1335-e1344. PubMed ID: 32971056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of Cost for Endoscopic Screening for Esophageal Cancer in a High-Risk Population in Rural China: Results from a Population-Level Randomized Controlled Trial.
    Li F; Li X; Guo C; Xu R; Li F; Pan Y; Liu M; Liu Z; Shi C; Wang H; Wang M; Tian H; Liu F; Liu Y; Li J; Cai H; Yang L; He Z; Ke Y
    Pharmacoeconomics; 2019 Jun; 37(6):819-827. PubMed ID: 30809788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity.
    Saumoy M; Schneider Y; Shen N; Kahaleh M; Sharaiha RZ; Shah SC
    Gastroenterology; 2018 Sep; 155(3):648-660. PubMed ID: 29778607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost-effectiveness analysis of esophageal cancer once-in-a-lifetime endoscopic screening in high-risk areas of rural China].
    Feng H; Song G; Yang J; Hao C; Wang M; Li B; Zhao D; Liu Z; Wei W; Qiao Y
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):476-80. PubMed ID: 26463155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.
    Yeh JM; Hur C; Ward Z; Schrag D; Goldie SJ
    Gut; 2016 Apr; 65(4):563-74. PubMed ID: 25779597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China.
    Zhao Z; Wang Y; Wu W; Yang Y; Du L; Dong H
    JAMA Netw Open; 2022 May; 5(5):e2213634. PubMed ID: 35608858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of Intensive vs Standard Blood Pressure Control Among Older Patients With Hypertension.
    Liao CT; Toh HS; Sun L; Yang CT; Hu A; Wei D; Melgarejo J; Zhang ZY
    JAMA Netw Open; 2023 Feb; 6(2):e230708. PubMed ID: 36848091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Priority setting in scaled-up cancer screening in China: an systematic review of economic evaluation evidences].
    Shi JF; Mao AY; Bai YN; Liu GX; Liu CC; Wang H; Cao MM; Feng H; Wang L; Bai FZ; Huang HY; Bai HJ; Zhu J; Yan XX; Zhang J; Ren JS; Li N; Dai M; Chen WQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Mar; 54(3):306-313. PubMed ID: 32187937
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.
    Geuzinge HA; Obdeijn IM; Rutgers EJT; Saadatmand S; Mann RM; Oosterwijk JC; Tollenaar RAEM; de Roy van Zuidewijn DBW; Lobbes MBI; van 't Riet M; Hooning MJ; Ausems MGEM; Loo CE; Wesseling J; Luiten EJT; Zonderland HM; Verhoef C; Heijnsdijk EAM; Tilanus-Linthorst MMA; de Koning HJ;
    JAMA Oncol; 2020 Sep; 6(9):1381-1389. PubMed ID: 32729887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-benefit analysis of esophageal cancer endoscopic screening in high-risk areas of China.
    Yang J; Wei WQ; Niu J; Liu ZC; Yang CX; Qiao YL
    World J Gastroenterol; 2012 May; 18(20):2493-501. PubMed ID: 22654446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing endoscopy and upper gastrointestinal X-ray for gastric cancer screening in South Korea: a cost-utility analysis.
    Chang HS; Park EC; Chung W; Nam CM; Choi KS; Cho E; Cho WH
    Asian Pac J Cancer Prev; 2012; 13(6):2721-8. PubMed ID: 22938448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness Analysis of the Helicobacter Pylori Screening Programme in an Asymptomatic Population in China.
    Feng T; Zheng Z; Xu J; Cao P; Gao S; Yu X
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.